Ownership history in UBS Group AG · 14 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in CELLECTAR BIOSCIENCES INC (CLRB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 2,598 | +1,690 | +186.1% | 0.00% | $8K | $2.95 |
| 2025 Q3 | REDUCED | 908 | -2,712 | -74.9% | 0.00% | $5K | $5.60 |
| 2025 Q2 | REDUCED | 3,620 | -916,732 | -99.6% | 0.00% | $26K | $7.11 |
| 2025 Q1 | ADDED | 920,352 | +544,153 | +144.6% | 0.00% | $290K | $9.60 |
| 2024 Q4 | ADDED | 376,199 | +373,622 | +14498.3% | 0.00% | $112K | $9.00 |
| 2024 Q3 | REDUCED | 2,577 | -12,223 | -82.6% | 0.00% | $6K | $64.20 |
| 2024 Q2 | ADDED | 14,800 | +8,850 | +148.7% | 0.00% | $37K | $75.00 |
| 2024 Q1 | ADDED | 5,950 | +4,750 | +395.8% | 0.00% | $24K | $119.40 |
| 2023 Q4 | REDUCED | 1,200 | -56 | -4.5% | 0.00% | $3K | $83.10 |
| 2023 Q3 | ADDED | 1,256 | +56 | +4.7% | 0.00% | $3K | $79.20 |
As of 2025 Q4 — sorted by position size